Lisata Therapeutics Inc (LSTA)

Lisata Therapeutics Inc stock is traded at $1.02, with a volume of 1,206. It is up +2.87% in the last 24 hours and down -15.70% over the past month. Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.